Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?

El Sherrif Y, Potts JR, Howard MR, Barnardo A, Cairns S, Knisely AS, Verma S.

Liver Int. 2013 Sep;33(8):1266-70. doi: 10.1111/liv.12216. Epub 2013 Jun 10.

PMID:
23750872
2.

ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.

Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, Bernard O, Jacquemin E.

Hepatology. 2010 May;51(5):1645-55. doi: 10.1002/hep.23539.

PMID:
20232290
3.

Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.

van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW.

Gastroenterology. 2004 Aug;127(2):379-84.

PMID:
15300568
4.

Characterization of ATP8B1 gene mutations and a hot-linked mutation found in Chinese children with progressive intrahepatic cholestasis and low GGT.

Liu LY, Wang XH, Wang ZL, Zhu QR, Wang JS.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):179-83. doi: 10.1097/MPG.0b013e3181c1b368.

PMID:
20038848
5.

Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.

Harmancı Ö, Ensaroğlu F, Özçay F, Öcal S, Korkmaz M, Özdemir BH, Selçuk H, Moray G, Haberal M.

Exp Clin Transplant. 2015 Nov;13 Suppl 3:107-9.

6.

Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.

van der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF, Houwen RH.

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):541-53. doi: 10.1016/j.bpg.2010.07.010. Review.

PMID:
20955958
7.

Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.

Deng BC, Lv S, Cui W, Zhao R, Lu X, Wu J, Liu P.

World J Gastroenterol. 2012 Nov 28;18(44):6504-9. doi: 10.3748/wjg.v18.i44.6504.

8.

Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.

Krishnan PV, Feng ZZ, Gordon SC.

J Clin Gastroenterol. 2009 Aug;43(7):672-5. doi: 10.1097/MCG.0b013e318188be6d.

PMID:
19238093
9.

Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A, Wanty C, Fischler B, Jacquemin E, Wali S, Blanchard S, Nielsen IM, Bourke B, McQuaid S, Lacaille F, Byrne JA, van Eerde AM, Kolho KL, Klomp L, Houwen R, Bacchetti P, Lobritto S, Hupertz V, McClean P, Mieli-Vergani G, Shneider B, Nemeth A, Sokal E, Freimer NB, Knisely AS, Rosenthal P, Whitington PF, Pawlowska J, Thompson RJ, Bull LN.

J Hepatol. 2010 Jul;53(1):170-8. doi: 10.1016/j.jhep.2010.01.034. Epub 2010 Apr 13.

10.

FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels.

Chen HL, Chang PS, Hsu HC, Ni YH, Hsu HY, Lee JH, Jeng YM, Shau WY, Chang MH.

J Pediatr. 2002 Jan;140(1):119-24.

PMID:
11815775
11.

Progressive familial intrahepatic cholestasis.

Jacquemin E.

Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9. Review.

PMID:
23141890
12.

Progressive familial intrahepatic cholestasis type 1.

Paulusma CC, Elferink RP, Jansen PL.

Semin Liver Dis. 2010 May;30(2):117-24. doi: 10.1055/s-0030-1253221. Epub 2010 Apr 26. Review.

PMID:
20422494
13.

Cholestasis in a patient with gallstones and a normal gamma-glutamyl transferase.

Moghadamrad S, Montani M, Weimann R, De Gottardi A.

Hepatology. 2013 Jun;57(6):2539-41. doi: 10.1002/hep.26344.

PMID:
23446990
14.

ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low gamma glutamyltransferase.

Liu LY, Wang ZL, Wang XH, Zhu QR, Wang JS.

Liver Int. 2010 Jul;30(6):809-15. doi: 10.1111/j.1478-3231.2009.02112.x. Epub 2009 Oct 21.

PMID:
19845854
15.

NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations.

Davit-Spraul A, Gonzales E, Jacquemin E.

Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):569-73. doi: 10.1016/j.clinre.2012.08.008. Epub 2012 Nov 9.

PMID:
23142591
16.

Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.

Alvarez L, Jara P, Sánchez-Sabaté E, Hierro L, Larrauri J, Díaz MC, Camarena C, De la Vega A, Frauca E, López-Collazo E, Lapunzina P.

Hum Mol Genet. 2004 Oct 15;13(20):2451-60. Epub 2004 Aug 18.

PMID:
15317749
17.

Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center.

Giovannoni I, Callea F, Bellacchio E, Torre G, De Ville De Goyet J, Francalanci P.

PLoS One. 2015 Dec 17;10(12):e0145021. doi: 10.1371/journal.pone.0145021. eCollection 2015.

18.

The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.

Wang NL, Li LT, Wu BB, Gong JY, Abuduxikuer K, Li G, Wang JS.

PLoS One. 2016 Apr 6;11(4):e0153114. doi: 10.1371/journal.pone.0153114. eCollection 2016.

19.

Current and future therapies for inherited cholestatic liver diseases.

van der Woerd WL, Houwen RH, van de Graaf SF.

World J Gastroenterol. 2017 Feb 7;23(5):763-775. doi: 10.3748/wjg.v23.i5.763. Review.

20.

Hepatotoxicity associated with dietary supplements containing anabolic steroids.

Kafrouni MI, Anders RA, Verma S.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):809-12. Epub 2007 May 16.

PMID:
17509944

Supplemental Content

Support Center